The CVCT Meeting is excited to announce a new feature this year: an invitation for Late-Breaking Clinical Trial Submissions! This is your chance to present impactful, cutting-edge clinical trial results at our prestigious meeting.
 
The CVCT meeting focuses on:
 → Improving the science of evidence generation.   
 → Accelerating trial execution.   
 → Advancing regulatory science.   
 → Accelerating approval of innovative therapies.   

This year's meeting will be held at The Mayflower Hotel in Washington, D.C., from December 8-10, 2025.
 
We are seeking submissions that highlight:
 → Novel methodologies and statistics.  
 → Innovative therapies at all clinical stages of development in CardioVascular – Kidney and Metabolic areas across therapeutic and management strategies, including drugs, devices, biologics, cell and gene therapies, technology and AI in medicine, and diagnostics, 

CVCT is unique because it promotes:
 → Brainstorming and moderated debates.   
 → Sharing detailed, non-competitive views and experiences.   
 → Inclusiveness of all perspectives.   

Presenting a Late-Breaking Clinical Trial at CVCT offers a unique platform to share your work with a group of experts with broad experience, including those from academia, clinicians, industry, regulatory bodies, payers, patients, and journal editors.   

Contribute to shaping the future of clinical trials and innovative therapies by submitting your late-breaking research!

​

Submit your abstract by October 15th 2025

Potential for simultaneous submission for publication in JACC